Robotic Surgical Companion Market Report 2026

Robotic Surgical Companion Market Overview

• Robotic Surgical Companion market size has reached to $6.9 billion in 2025 • Expected to grow to $13.07 billion in 2030 at a compound annual growth rate (CAGR) of 13.5% • Growth Driver: Rising Cancer Incidence Driving The Growth Of The Market Due To Increasing Need For Precise And Minimally Invasive Treatments • Market Trend: Technological Advancements Driving Precision And Efficiency In Surgical Procedures • North America was the largest region in 2025.

What Is Covered Under Robotic Surgical Companion Market?

A robotic surgical companion refers to an advanced robotic system designed to assist surgeons during surgical procedures by providing precision, enhanced dexterity, and real-time guidance, thereby improving surgical outcomes and reducing procedural risks. It also helps streamline complex surgical tasks, allowing for minimally invasive approaches and faster patient recovery. The main components of robotic surgical companions are hardware, software and services. Hardware comprises the physical elements that make up the robotic system, including product types such as surgical robots, robotic surgical assistants, robotic navigation systems, and others. These are applied in general surgery, urology, gynecology, orthopedics, cardiovascular, neurosurgery, and others, serving end-users including hospitals, ambulatory surgical centers, specialty clinics, and others.

What Is The Robotic Surgical Companion Market Growth Forecast?

The robotic surgical companion market size is expected to see rapid growth in the next few years. It will grow to $13.07 billion in 2030 at a compound annual growth rate (CAGR) of 13.5%. The growth in the forecast period can be attributed to AI-enabled surgical assistance, expansion of robotic surgery training, growing outpatient surgeries, demand for faster patient recovery, integration with imaging systems. Major trends in the forecast period include precision-assisted surgical procedures, minimally invasive robotic surgery, surgeon guidance and decision support, enhanced surgical dexterity systems, operating room workflow optimization.

What Is The Driver Of The Robotic Surgical Companion Market?

The increasing prevalence of cancer is expected to propel the growth of the robotic surgical companion market going forward. Cancer is a condition where the body’s cells multiply uncontrollably, damaging nearby tissues and potentially spreading to other areas of the body. Cancer cases are rising mainly due to unhealthy lifestyles, such as poor diet, lack of exercise, and tobacco use, which increase the risk of cell damage and uncontrolled cell growth. Robotic surgical companions aid in cancer treatment by performing highly accurate, minimally invasive procedures that minimize harm to healthy tissues and help patients recover more quickly. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, the number of new cancer cases is expected to exceed 35 million by 2050, marking a 77% rise compared to the approximately 20 million cases recorded in 2022. Therefore, the increasing prevalence of cancer is driving the growth of the robotic surgical companion industry.

Key Players In The Global Robotic Surgical Companion Market

Major companies operating in the robotic surgical companion market are Intuitive Surgical Inc., Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Asensus Surgical Inc., Globus Medical Inc., Distalmotion SA, Medicaroid Corporation, CMR Surgical Ltd., Johnson & Johnson, Smith & Nephew plc, eCential Robotics SAS, Renishaw plc, Meere Company Inc., avateramedical GmbH, Robocath SAS, Preceyes B.V., Neocis Inc., Microbot Medical Inc., NDR Medical Technology Pte. Ltd., Accuray Incorporated

Global Robotic Surgical Companion Market Trends and Insights

Major companies operating in the robotic surgical companion market are focusing on developing advanced solutions, such as AI-powered robotic surgery systems to enhance surgical precision, reduce operative time, and improve patient outcomes. AI-powered robotic surgery system refers to a surgical platform that combines artificial intelligence algorithms with robotic instruments to assist surgeons in planning, guiding, and performing procedures with enhanced precision, accuracy, and efficiency. For instance, in July 2025, CARE Hospitals, an India-based healthcare provider, launched a Stryker Mako Robotic System to enhance precision in orthopedic surgeries. It is an advanced AI-powered technology that enables highly precise, personalized joint replacement surgeries using detailed 3D modeling and real-time robotic guidance. Its main benefits include improved surgical accuracy, reduced tissue damage, less postoperative pain, faster recovery, and more predictable outcomes. The system's purpose is to enhance the quality and consistency of orthopedic surgeries, helping patients achieve better long-term joint function with shorter hospital stays and fewer complications compared to traditional methods.

What Are Latest Mergers And Acquisitions In The Robotic Surgical Companion Market?

In October 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, acquired Monogram Technologies Inc. for an undisclosed amount. With this acquisition, Zimmer Biomet Holdings Inc. aims to lead orthopedic surgery innovation by offering the first fully autonomous robotic solutions, expanding its robotics portfolio with Monogram's AI-driven technologies to improve surgical outcomes and provide surgeons with the most comprehensive robotic ecosystem. Monogram Technologies Inc. is a US-based medical device company that offers robotic surgical companion.

What Defines the Robotic Surgical Companion Market?

The robotic surgical companion market consists of revenues earned by entities providing services such as robotic-assisted surgery, surgical planning and navigation support, real-time intraoperative guidance, system maintenance and software updates, and training and simulation for surgeons. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic surgical companion market also includes sales of robotic instrument holders, robotic endoscopic systems, and haptic feedback devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Robotic Surgical Companion Market Report 2026?

The robotic surgical companion market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgical companion industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.